Showing 20 of 92 recruiting trials for “Cystic fibrosis”
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
BEGIN Novel ImagiNG Biomarkers
👨⚕️ Jason Woods, PhD, Children's Hospital Medical Center, Cincinnati📍 3 sites📅 Started May 2022View details ↗
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
RecruitingNCT05099939 ↗
Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis
👨⚕️ Rémi Rabasa-Lhoret, Institut de recherches cliniques de Montréal📍 4 sites📅 Started Nov 2021View details ↗
RecruitingNCT05279040 ↗
Trikafta Exercise Study in Cystic Fibrosis
Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
👨⚕️ Jonathan Rayment, MDCM, University of British Columbia📍 2 sites📅 Started Nov 2021View details ↗
Markers of Osteoporosis in Cystic Fibrosis
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
RecruitingNCT06413459 ↗
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
Regional Phenotyping of CF and Non-CF Bronchiectasis
RecruitingNCT06057714 ↗
Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis
Enrolling by InvitationNCT04579211 ↗
Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Exercise in Child Health
Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
👨⚕️ Silke van Koningsbruggen-Rietschel, MD, PhD, University Hospital Cologne📍 1 site📅 Started Oct 2020View details ↗
RecruitingNCT04469439 ↗
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
👨⚕️ Daniel M Beswick, MD, University of California, Los Angeles📍 9 sites📅 Started Jul 2020View details ↗
RecruitingNCT04002882 ↗
Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)
Effects of AD on VI in Patients With CF
👨⚕️ Gregory Reychler, PT, PhD, Cliniques universitaires Saint-Luc- Université Catholique de Louvain📍 1 site📅 Started Aug 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →